Mounjaro®
Starting from £179.99/mo
Start journey Learn moreVomiting on semaglutide usually settles within a few days to two weeks of starting treatment or increasing a dose — most people find it peaks in the first 24 to 48 hours and then fades as the body adjusts. It is one of the most common side effects of Wegovy, and while it can feel alarming, it rarely signals a serious problem. These are prescription-only medicines, and any side effects that concern you are worth raising with your prescriber rather than managing alone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide slows gastric emptying, the rate at which food moves from the stomach into the small intestine. That slowing is central to how the medicine works, but it is also the main reason the stomach protests, especially at first. Food lingers longer than the body expects, and vomiting can follow.
In the first day or two after beginning treatment or stepping up to a new strength, this effect tends to be at its strongest. The full side-effect picture with Wegovy is broader than vomiting alone, but nausea and vomiting together are what people notice most sharply in this window. Eating smaller portions, avoiding rich or fatty meals, and staying upright for a while after eating can all reduce the intensity. Sipping water steadily (rather than drinking large amounts at once) also helps.
A question our prescribers hear most weeks is whether the vomiting means the medicine is not right for a particular person. Usually, it does not. It is a pharmacological response, not a sign of intolerance, and if you are wondering how long vomiting typically lasts with Wegovy, the answer for most people is that it eases with time and simple adjustments.
By the end of the first week, vomiting typically begins to settle. The NHS patient information for semaglutide describes gastrointestinal side effects as common and notes they tend to improve as treatment continues. Most people find they have turned a corner by the end of the second week, though the pace varies.
What can extend this window? Eating too quickly, consuming high-fat foods, or drinking alcohol. Large meals are particularly problematic when gastric emptying is already slowed. If vomiting is happening most days beyond the two-week mark, that is a signal to contact your prescriber, not to abandon treatment without advice, but to review whether the titration pace suits you. Slowing the dose escalation is a recognised and legitimate clinical option. You can read more about how the pattern of semaglutide side effects resolves over time on a dedicated page.
Keeping a simple note of when vomiting happens and what you had eaten beforehand can be genuinely useful for that conversation. Patterns matter clinically.
Most vomiting on semaglutide is unpleasant rather than dangerous. There are circumstances, though, where it moves into a different category and needs prompt medical assessment.
In January 2026 the MHRA issued a Drug Safety Update on GLP-1 medicines, specifically flagging acute pancreatitis as an infrequent but serious risk. The warning sign is severe stomach pain that does not ease and spreads toward the back, with or without vomiting. That combination warrants same-day contact with a GP or, if the pain is severe and rapid in onset, attending A&E. Do not wait to see if it passes.
Dehydration is a more common concern. If vomiting is frequent enough that you cannot keep fluids down for several hours, that needs attention too, particularly if you feel faint, have a dry mouth, or are passing very little urine. The interaction between diarrhoea and vomiting on Wegovy can accelerate fluid loss faster than either alone. An allergic reaction (characterised by swelling of the face, lips or throat, or difficulty breathing) is rare but requires emergency care immediately.
If you are uncertain, contacting your prescriber or calling 111 is always the right call. Side effects that feel different from what you were told to expect are worth flagging via the Yellow Card scheme as well; that reporting helps the MHRA monitor safety signals in the real world.
Beyond the timeline, there are concrete things that help. Smaller, more frequent meals reduce the load on a stomach that is already emptying slowly. Plain foods (rice, toast, boiled potatoes) are easier to tolerate than anything rich, spiced, or high in fat. Cold or room-temperature food tends to provoke less nausea than hot dishes for some people. Ginger, in tea or tablet form, has a reasonable evidence base for nausea generally, though the evidence specific to GLP-1 medicines is limited.
The relationship between meals and vomiting on semaglutide is worth understanding in more detail if eating triggers it reliably, timing your weekly injection, the size of your portions, and the gap between eating and lying down all interact. Your prescriber is the right person to help you find a pattern that works, and that conversation is part of the clinical support you should expect, not an inconvenience.
People who are considering Wegovy for the first time, or transferring from another treatment, can explore what the consultation process at nume involves. Our prescribers cover side-effect management as a standard part of assessing suitability, not as an afterthought.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.